Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Burioni

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Blocking immunodominant epitopes by competitive deselectionRoberto Burioni
Journal of Translational Medicine|April 10, 2023
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?Renata Gili, Roberto Burioni
Nature Medicine|March 2, 2021
Assessing the human immune response to SARS-CoV-2 variantsRoberto Burioni, Eric J Topol
Nature Medicine|June 22, 2021
Has SARS-CoV-2 reached peak fitness?Roberto Burioni, Eric J Topol
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Microbiological diagnosis of sepsis: the confounding effects of a "gold standard"Nicasio Mancini, Roberto Burioni, Massimo Clementi
Nature|February 26, 2020
Lessons from Italy's policy shift on immunizationRoberto Burioni, Anna Odone, Carlo Signorelli
The New England Journal of Medicine|August 31, 2012
Natalizumab-associated progressive multifocal leukoencephalopathyNicasio Mancini, Massimo Clementi, Roberto Burioni
Lancet (London, England)|October 27, 2009
Pregnancy and H1N1 infectionRoberto Burioni, Filippo Canducci, Massimo Clementi
Nature|March 2, 2018
Lessons from Italy's policy shift on immunizationRoberto Burioni, Anna Odone, Carlo Signorelli
Internal and Emergency Medicine|May 27, 2026
Commercial foodborne botulism in Italy: reinforcing vigilance through scientific rigourFrancesco M Galassi, Elena Varotto, Roberto Burioni
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2002
Blocking immunodominant epitopes by competitive deselectionRoberto Burioni
Journal of Translational Medicine|April 10, 2023
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?Renata Gili, Roberto Burioni
Nature Medicine|March 2, 2021
Assessing the human immune response to SARS-CoV-2 variantsRoberto Burioni, Eric J Topol
Nature Medicine|June 22, 2021
Has SARS-CoV-2 reached peak fitness?Roberto Burioni, Eric J Topol
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Microbiological diagnosis of sepsis: the confounding effects of a "gold standard"Nicasio Mancini, Roberto Burioni, Massimo Clementi
Nature|February 26, 2020
Lessons from Italy's policy shift on immunizationRoberto Burioni, Anna Odone, Carlo Signorelli
The New England Journal of Medicine|August 31, 2012
Natalizumab-associated progressive multifocal leukoencephalopathyNicasio Mancini, Massimo Clementi, Roberto Burioni
Lancet (London, England)|October 27, 2009
Pregnancy and H1N1 infectionRoberto Burioni, Filippo Canducci, Massimo Clementi
Nature|March 2, 2018
Lessons from Italy's policy shift on immunizationRoberto Burioni, Anna Odone, Carlo Signorelli
Internal and Emergency Medicine|May 27, 2026
Commercial foodborne botulism in Italy: reinforcing vigilance through scientific rigourFrancesco M Galassi, Elena Varotto, Roberto Burioni
Pageof 11